Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts said.

Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...

Solano County issued a countywide Shelter at Home Health Order and Directive to continue protecting the health and safety of ...

If Medicaid is taken away, children could still receive vaccination coverage through a variety of other programs, including the Children's Health Insurance Program or the Title V Maternal and Child ...

WASHINGTON: The White House withdrew President Donald Trump's nomination of former Republican congressman and vaccine critic ...

Convincing professionals, software engineers and other application developers to open their wallets for new artificial ...